Masaki Munakata

523 total citations
39 papers, 320 citations indexed

About

Masaki Munakata is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Masaki Munakata has authored 39 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Masaki Munakata's work include Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (13 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Masaki Munakata is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (13 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Masaki Munakata collaborates with scholars based in Japan and United States. Masaki Munakata's co-authors include Yuh Sakata, Kohei Shitara, Wasaburo Koizumi, Ichinosuke Hyodo, Taito Esaki, Takashi Ura, Yoshito Komatsu, Taroh Satoh, Tomohiro Nishina and Shu Okamura and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Masaki Munakata

34 papers receiving 315 citations

Peers

Masaki Munakata
Comparison fields: 5 of 46
  • Oncology 217
  • Pulmonary and Respiratory Medicine 156
  • Surgery 92
  • Molecular Biology 67
  • Hepatology 43
Replace Azusa Komori with:
Azusa Komori Japan
Carrie Luu United States
Melvin Lau United States
Marco Filetti Italy
Chuan‐Pau Siauw Taiwan
Vikas Ostwal India
Bilal Al‐Sarireh United Kingdom
Naomi Tanaka Japan
Giuseppina Arcangeli Italy
Olga Kozyreva United States
Azusa Komori Japan View profile →
Citations per field, relative to Masaki Munakata
Masaki Munakata · 1×
Citations per year, relative to Masaki Munakata
Masaki Munakata · 1×

Countries citing papers authored by Masaki Munakata

Since Specialization
Citations

This map shows the geographic impact of Masaki Munakata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Munakata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Munakata more than expected).

Fields of papers citing papers by Masaki Munakata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Munakata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Munakata. The network helps show where Masaki Munakata may publish in the future.

Co-authorship network of co-authors of Masaki Munakata

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Munakata. A scholar is included among the top collaborators of Masaki Munakata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Munakata. Masaki Munakata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 18
3
Successful Treatment with 5-fluorouracil and Levofolinate Calcium in Advanced Gastric Cancer Patient with Disseminated Intravascular Coagulation.
0
4 14
5 17
6 82
7
PHASE II TRIAL OF COMBINED CHEMOTHERAPY WITH IRINOTECAN, S-1, AND BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
1
8 7
9 3
10 4
11 5
12 29
13 4
14 10
15
A case of suspected S-1 induced interstitial pneumonia.
5
16 3
17 4
18 57
19
[Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer].
11
20
[Successful treatment of 5-FU intraarterial infusion on the third postoperative day for a patient with multiple liver metastases from colon cancer and high risk of liver failure].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026